ArticleTherapeutic advances in urology

Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?

Giandomenico Roviello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.